adenosine diphosphate ribose has been researched along with Asystole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bährle, S; Cziráki, A; Flechtenmacher, C; Gries, A; Hagl, S; Heger, U; Mandera, S; Seres, L; Soós, P; Szabó, C; Szabó, G; Vahl, CF; Zsengellér, Z | 1 |
1 other study(ies) available for adenosine diphosphate ribose and Asystole
Article | Year |
---|---|
INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
Topics: Acetylcholine; Adenosine Diphosphate Ribose; Animals; Disease Models, Animal; Dogs; Enzyme Inhibitors; Free Radicals; Heart; Heart Arrest; Heart Arrest, Induced; Immunohistochemistry; Indoles; Inflammation; Lung; Muscle Contraction; Myocardial Reperfusion Injury; Myocardium; Nitroprusside; Oxygen; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Regional Blood Flow; Reperfusion Injury; Time Factors | 2004 |